Riken Vitamin Co., Ltd. / Fundamentals

    Income statement

    Net revenue
    €541.69M
    Cost of goods sold
    €364.48M
    Gross profit
    €177.22M
    SG&A expenses
    €127.77M
    R&D expenses
    €0.00
    EBITDA
    €87.29M
    D&A
    €18.55M
    EBIT
    €49.44M
    Interest expenses
    €510.06K
    EBT
    €72.02M
    Tax expenses
    €18.78M
    Net income
    €53.22M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    -€53.20M
    Changes in working capital
    €0.00
    Operating cash flow
    €0.00
    Capex
    €0.00
    Other investing cash flow
    €0.00
    Net investing cash flow
    €0.00
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €0.00
    Debt repayment
    €0.00
    Other financing cash flow
    €0.00
    Net financing cash flow
    €0.00
    Foreign exchange effects
    €0.00
    Net change in cash
    €0.00
    Cash at end of period
    €0.00
    Free cash flow
    €0.00

    Balance sheet

    Cash and cash equivalents
    €126.37M
    Cash and short-term investments
    €126.37M
    Total receivables
    €123.59M
    Inventory
    €111.14M
    Other current assets
    €11.24M
    Total current assets
    €372.34M
    Property, plant & equipment
    €144.66M
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €85.45M
    Other non-current assets
    €28.89M
    Total non-current assets
    €268.06M
    Total assets
    €640.40M
    Accounts payable
    €44.77M
    Short-term debt
    €19.12M
    Other current liabilities
    €55.86M
    Total current liabilities
    €119.74M
    Long-term debt
    €37.07M
    Deferred tax liabilities
    €21.58M
    Other non-current liabilities
    €13.14M
    Total non-current liabilities
    €71.79M
    Total liabilities
    €191.54M
    Common stock
    €14.38M
    Retained earnings
    €367.10M
    Other equity
    €64.24M
    Total equity
    €448.85M
    Total liabilities and shareholders' equity
    €640.40M

    Company information

    Market capitalization
    €468.53M
    Employees
    1.9K
    Enterprise Value
    €47.84B

    Company ratios

    Gross margin
    32.7% Even with peer group: 37.0%
    EBITDA margin
    16.1% Better than peer group: 9.6%
    EBIT margin
    9.1% Even with peer group: 6.2%
    EBT margin
    13.3% Better than peer group: 6.8%
    Net margin
    9.8% Even with peer group: 4.8%
    ROE
    11.9% Better than peer group: 5.7%
    ROA
    8.3% Even with peer group: 3.7%
    Asset turnover
    84.6% Even with peer group: 87.4%
    FCF margin
    0.0%
    FCF yield
    0.0%
    Efficiency ratio
    83.9%
    Net sales per employee
    €291.70K
    Net income per employee
    €28.66K

    Notifications